Opus Genetics is trading 5.2% down at $3.10 today as the stock extends a sharp multi-day pullback from recent rebound levels.
- There are currently no fresh company-specific headlines, filings, or analyst actions explaining the downward move.
- Today’s price action suggests a continuation of recent volatility in smaller biotech names rather than a reaction to new fundamental information.